- High
- —
- Open
- —
- VWAP
- —
- Vol
- —
- Mkt Cap
- —
- Low
- —
- Amount
- —
- EV/EBITDA, TTM
- —
Shockwave Medical, Inc. is a medical device company. The Company is primarily engaged in the development and commercialization of novel technologies that transform the care of patients with cardiovascular disease. The Company is focused on its intravascular lithotripsy (IVL) technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular and heart valve disease. Built on a balloon catheter platform, the IVL technology uses lithotripsy to disrupt both superficial and deep vascular calcium., while minimizing soft tissue injury, and an integrated angioplasty balloon to dilate blockages at low pressures, restoring blood flow. Its Shockwave M5 IVL catheter and Shockwave M5+ IVL catheter are five-emitter catheters for use in its IVL System in medium-diameter vessels for the treatment of peripheral artery disease (PAD). Its Shockwave S4 IVL catheter is a four-emitter catheter for use in its IVL System in small-diameter vessels for the treatment of PAD.
News
8.503-24PRnewswireSonder Capital Closes Second Fund Futures II to Transform Patient Care
8.503-24NewsfilterSonder Capital Closes Second Fund Futures II to Transform Patient Care
5.002-21NewsfilterBruker Appoints Laura Francis to its Board of Directors
9.501-22Investing.comJ&J beats quarterly sales and profit estimates on cancer drug sales By Reuters
- 8.501-13Investing.com
J&J doubles down on neurological drugs with $14.6 billion Intra-Cellular deal By Reuters
SWAV FAQ — answered by Alphio AI
Shockwave Medical, Inc. is a medical device company. The Company is primarily engaged in the development and commercialization of novel technologies that transform the care of patients with cardiovascular disease. The Company is focused on its intravascular lithotripsy (IVL) technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular and heart valve disease. Built on a balloon catheter platform, the IVL technology uses lithotripsy to disrupt both superficial and deep vascular calcium., while minimizing soft tissue injury, and an integrated angioplasty balloon to dilate blockages at low pressures, restoring blood flow. Its Shockwave M5 IVL catheter and Shockwave M5+ IVL catheter are five-emitter catheters for use in its IVL System in medium-diameter vessels for the treatment of peripheral artery disease (PAD). Its Shockwave S4 IVL catheter is a four-emitter catheter for use in its IVL System in small-diameter vessels for the treatment of PAD. It operates in the Healthcare sector (SURGICAL & MEDICAL INSTRUMENTS & APPARATUS industry).
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.